Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential COVID-19 Outcomes Across Lysosomal Disorders.

medRxiv : the preprint server for health sciences·2026
Same author

A unique poikilodermatous condition associated with a de novo heterozygous ATR missense variant.

Clinical and experimental dermatology·2026
Same author

Multimodal Genotype-Phenotype Analysis in SMARCB1-Associated Developmental Disorders.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Variant classification for mucopolysaccharidosis type I; ACMG/AMP specification for IDUA from the ClinGen lysosomal diseases variant curation expert panel.

Molecular genetics and metabolism·2026
Same author

Unusual Glomerular Abnormalities in a Patient With Combined <i>COL4A5-NPHS1</i> Variants.

Kidney medicine·2026
Same author

Do words matter? The role of terminology and causal attributions in prejudice towards people with mental health conditions.

Journal of mental health (Abingdon, England)·2026
Same journal

How does Léri-Weill Dyschondrosteosis Affect Adults' Health-Related Quality of Life? - A Norwegian Cross-Sectional Study Exploring the Physical and Mental Burden.

American journal of medical genetics. Part A·2026
Same journal

Re-Identification of the Panamanian Guna/Kuna/Cuna OCA2 Founder Association Through Two American-Born Siblings.

American journal of medical genetics. Part A·2026
Same journal

Biallelic Variant in HAPLN1 is Associated With Skeletal Dysplasia With or Without Congenital Heart Disease.

American journal of medical genetics. Part A·2026
Same journal

MYH11-Related Hereditary Type 2 Visceral Myopathy in a Large Kindred: Diagnostic Odyssey With Milder Clinical Manifestations.

American journal of medical genetics. Part A·2026
Same journal

Positron Emission Tomography (PET) in Phenylketonuria: A Systematic Review of Brain Metabolism Beyond Phenylalanine.

American journal of medical genetics. Part A·2026
Same journal

Re: "Clinical Insights From a Case of Sifrim-Hitz-Weiss Syndrome With a CHD4 Variant: Expanding the Phenotypic Spectrum and Its Response to Growth Hormone Therapy".

American journal of medical genetics. Part A·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K

Identification of a Non-Coding Causative Variant Underlying Warsaw Breakage Syndrome Using Long-Read Based Genomic

Makenna DuBois1, Katherine Dixon2, Charlotte Sherlaw-Sturrock3

  • 1Department of Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine, California, USA.

American Journal of Medical Genetics. Part A
|September 12, 2025
PubMed
Summary
This summary is machine-generated.

Multi-modal genome sequencing identified a novel DDX11 gene deletion in siblings with rare genetic disorders. This approach expands variant detection beyond protein-coding regions, improving rare disease diagnosis.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K

Area of Science:

  • Genomics
  • Rare Genetic Diseases
  • Molecular Biology

Background:

  • Exome and genome sequencing diagnose 30%-50% of rare genetic diseases.
  • Interrogating non-coding regions with multi-modal technologies can improve diagnostic yield.
  • A family presented with sensorineural hearing loss, microcephaly, intellectual impairment, and growth restriction.

Purpose of the Study:

  • To identify the genetic cause of rare diseases in siblings using advanced sequencing techniques.
  • To demonstrate the utility of multi-modal genome-wide approaches for diagnosing rare genetic conditions.

Main Methods:

  • Long-read whole genome and cDNA-based transcriptome sequencing on the Oxford Nanopore platform.
  • Analysis of non-coding genomic regions, including the 5' UTR and promoter.
  • Integration of multi-modal data for variant prioritization.

Main Results:

  • A homozygous 1.6 kb deletion in the 5' UTR and promoter region of the DDX11 gene was identified.
  • The deletion encompassed a regulatory CpG island, leading to loss of DDX11 mRNA and protein expression.
  • The characteristic "railroad chromosome" phenotype was observed, consistent with Warsaw breakage syndrome.

Conclusions:

  • Expanding genomic variant searches beyond protein-coding regions is crucial for diagnosing rare diseases.
  • Multi-modal data integration enhances variant classification and diagnostic capabilities.
  • This genome-wide approach offers hope for patients with undiagnosed genetic conditions.